RE:RE:RE:RE:Best advicemakingmoney1 wrote: I hope all you guys are from quebec...because here in ontario, I'd like to think we are at least a bit aware of how to value a company. When hip is at 2 dollars and this is stuck at 20 cents...we can have this debate again. And dilution isn't important if you aren't taking market cap into perspective. Cmed/hip deal will fall through...hip will move on solo until another company offers a better valuation...i will make a ton of money. Investors that pumped this stock will take losses/profits by the years end, and move to far safer investments riding into legalization. This company simply wont have immediate sales to make a difference. They'll be playing catchup well into 2019 and I think its hilarious if you guys don't have the foresight to see that. Have fun shutting down experienced investors with more common sense than you. I'll leave you guys alone
This is too funny I'm from Ontario, been buying weed stocks since late 2013 and know how to value companies by cap or by asset/ financials . I own 39 different weed stocks including all the big boys and never bothered with buying HIP yet. I hope for you HIP get that deal with CMED and don't trade back in the .30 range. ACB will squash that deal because it's still being overvalued @33:1 Don't get me wrong I don't normally bash stocks ( not trying to with HIP )and may still make entry in Hip for a small spec position